(Total Views: 772)
Posted On: 09/16/2020 8:45:11 PM
Post# of 145881
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Today's conference call was bad because of communication problems, not because of the content of the call.
The share price might hold above $3 tomorrow, maybe even above $3.50.
Pourhassan is in the middle of a tremendously chaotic situation at the moment, and he just doesn't have the tools to simultaneously communicate the nature of the chaos as well as provide clear statements as to what CYDY is doing to negotiate the chaos.
While providing frequent updates has been a staple of Pourhassan's style to maintain transparency, Pourhassan's execution of that style has become a drag on the share price, and the extent of that drag will be visible tomorrow.
The chaos is pretty severe with big issues in many areas, including NASDAQ, CD10, CD12, MHRA, FDA, HIV, BLA, cancer, and still other areas.
The chaos is so severe that a simple task like authorizing shares for new hires (CYDY has near zero) morphs into a conversation about whether or not Pourhassan is simply attempting to enrich himself.
Certainly a legitimate argument that Pourhassan is not competent to negotiate this chaos.
It is also very chaotic to have so many people chiming in on the conference call.
All these facts could be reported in a press release or slide deck.
Poor chaos management causes a share price discount.
The share price might hold above $3 tomorrow, maybe even above $3.50.
Pourhassan is in the middle of a tremendously chaotic situation at the moment, and he just doesn't have the tools to simultaneously communicate the nature of the chaos as well as provide clear statements as to what CYDY is doing to negotiate the chaos.
While providing frequent updates has been a staple of Pourhassan's style to maintain transparency, Pourhassan's execution of that style has become a drag on the share price, and the extent of that drag will be visible tomorrow.
The chaos is pretty severe with big issues in many areas, including NASDAQ, CD10, CD12, MHRA, FDA, HIV, BLA, cancer, and still other areas.
The chaos is so severe that a simple task like authorizing shares for new hires (CYDY has near zero) morphs into a conversation about whether or not Pourhassan is simply attempting to enrich himself.
Certainly a legitimate argument that Pourhassan is not competent to negotiate this chaos.
It is also very chaotic to have so many people chiming in on the conference call.
All these facts could be reported in a press release or slide deck.
Poor chaos management causes a share price discount.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)